Literature DB >> 24010450

Optical transverse injection in laser-plasma acceleration.

R Lehe1, A F Lifschitz, X Davoine, C Thaury, V Malka.   

Abstract

Laser-wakefield acceleration constitutes a promising technology for future electron accelerators. A crucial step in such an accelerator is the injection of electrons into the wakefield, which will largely determine the properties of the extracted beam. We present here a new paradigm of colliding-pulse injection, which allows us to generate high-quality electron bunches having both a very low emittance (0.17 mm·mrad) and a low energy spread (2%), while retaining a high charge (~100 pC) and a short duration (3 fs). In this paradigm, the pulse collision provokes a transient expansion of the accelerating bubble, which then leads to transverse electron injection. This mechanism contrasts with previously observed optical injection mechanisms, which were essentially longitudinal. We also specify the range of parameters in which this new type of injection occurs and show that it is within reach of existing high-intensity laser facilities.

Year:  2013        PMID: 24010450     DOI: 10.1103/PhysRevLett.111.085005

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  3 in total

1.  A focused very high energy electron beam for fractionated stereotactic radiotherapy.

Authors:  Kristoffer Svendsen; Diego Guénot; Jonas Björklund Svensson; Kristoffer Petersson; Anders Persson; Olle Lundh
Journal:  Sci Rep       Date:  2021-03-12       Impact factor: 4.379

2.  A compact tunable polarized X-ray source based on laser-plasma helical undulators.

Authors:  J Luo; M Chen; M Zeng; J Vieira; L L Yu; S M Weng; L O Silva; D A Jaroszynski; Z M Sheng; J Zhang
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

3.  Controlled electron injection facilitated by nanoparticles for laser wakefield acceleration.

Authors:  Myung Hoon Cho; Vishwa Bandhu Pathak; Hyung Taek Kim; Chang Hee Nam
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.